PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Schott: Tue 17 September 2024, 10:51
Biosynth: Fri 4 October 2024, 10:42
Get Ownership of your IP Right; Otherwise it can Turn into a Nightmare!
Editorial Archive

Get Ownership of your IP Right; Otherwise it can Turn into a Nightmare!

When filing a patent application, there are lots of things to consider. Most of the attention is directed towards getting the disclosure of the invention right and e...
Continue Reading →
Global Tracking Regulations Present Challenges and Benefits
Editorial Archive

Global Tracking Regulations Present Challenges and Benefits

Lars Hoejberg of NNIT looks into serialisation, the foundation of any tracking system. Drug makers are facing an ever-increasing challenge as more countries implemen...
Continue Reading →
Funding Options for R&D in the Life Sciences Sector
Editorial Archive

Funding Options for R&D in the Life Sciences Sector

Typically, funding for R&D and business growth has been hard to secure over previous years due to the financial crisis. However, now that the financial uncertain...
Continue Reading →
The 3E Principle: Key Considerations for Selecting and Outsourcing to a Vendor
Editorial Archive

The 3E Principle: Key Considerations for Selecting and Outsourcing to a Vendor

Influenced by forces such as macroeconomics, politics, regulations, population growth and aging, there has been a major shift in the way biopharmaceutical companies ...
Continue Reading →
The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists
Editorial Archive

The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists

Pharmaceutical companies have widely adopted strategies to outsource elements of their business operations, as part of an ongoing drive to deliver a more flexible mo...
Continue Reading →
Regulatory Scenario of Herbal Medicines: A Global Review
Editorial Archive

Regulatory Scenario of Herbal Medicines: A Global Review

In the last few decades there has been exponential growth in the field of herbal medicine and regulation of herbal medicines has become key to ensuring the safety, e...
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49